Overview
The report reviewed and updated Australia's national grapevine germplasm register, finding around 900 varieties and clones held across 16 collections, with considerable duplication, inconsistent naming and limited DNA-based identity verification (under 7% of accessions tested). Australia's two largest collections, CSIRO and SARDI, were closed to industry at the time, despite being ranked, alongside AVIA and RVIC, as best placed to meet future industry priorities. It compares funding models, health-testing standards and access practices at international grapevine collections in Germany, France, Portugal and the USA, and at other Australian perennial industries including citrus, almonds, pome fruit and forestry, most of which carry stronger government funding and additional income streams. The report recommends rationalising Australia's collections, and pursuing a risk assessment, strategic plan and management board to guide future investment.
Abstract
Downloads
Categories










